Thiruvananthapuram: Rajiv Gandhi Centre for Biotechnology (RGCB) was selected as one of the four next-generation sequencing (NGS) hubs for Metagenomic.

The Rajiv Gandhi Centre for Biotechnology becomes a national Next-Generation Sequencing hub, aiming to combat acute febrile ...

Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion ...

Burning Rock Biotech Limited (NASDAQ: BNR, the 'Company” or 'Burning Rock”), a company focusing on the application of next ...

The Global MRD Testing Market is expanding due to rising cancer and hematological malignancy rates and advances in diagnostic ...

Zymo Research partners with biomodal to offer advanced multiomic sequencing, enabling 5mC, 5hmC and genetic analysis from a ...

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

The DTC Genetic Testing Market is poised for growth, driven by rising health awareness and demand for personalized insights.

Global STD Diagnostics Market OverviewThe global STD diagnostics market is on a steady upward trajectory, projected to grow at a CAGR of 7–8% during the forecast period. This expansion is supported by ...

Wall Street analysts, who acted as lead underwriters for BillionToOne's Nasdaq debut last month, began coverage of the diagnostics firm on Monday with broadly upbeat views, pointing to its advanced ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

JPMorgan initiated coverage of BillionToOne (BLLN) with an Overweight rating and $150 price target BillionToOne is a molecular diagnostics company ...